CELLINK

Company Snapshot

Founded: 2016
Entity Type: Private
Region: Sweden
Headquarter: Gothenburg, Sweden
Key Geographics: Sweden
Corporate Address: Langfilsgatan 1, 412 77 Gothenburg, Sweden Tel. +46-31-12-8700 www.cellink.com

Company Overview

Founded in 2016, CELLINK, a division of BICO, produces bioprinters, bioinks, software, and services used across the healthcare industry. The company provides on-demand bioprinting of human organs and tissues. The company operates in more than 65 locations across multiple geographies, such as North America, Europe, the Middle East, and Asia-Pacific.

CELLINK In Reports

Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets

BCC Research Market Analyst says global market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $2.8 billion in 2024 to reach $5.0 billion by 2029.

3D Printing Medical Devices: Global Markets

BCC Research Market Analyst says global market for 3D printing medical devices reached $2.1 billion in 2023 & estimated to grow from $2.2 billion in 2024 to $4.5 billion by the end of 2029.

Bioprinting: Technologies and Global Markets

Global bioprinting technologies market should reach $5.0 billion by 2027 from $2.4 billion in 2022 at a CAGR of 16.2% for the forecast period of 2022-27.

Company's Business Segments

  • 3D Bioprinting : This segment includes Bioprinters, Biodispensing, Bioinks, 3D cell culturing.

Applications/End User Industries

  • Academic Researchers
  • Drug Discovery
  • Personalized Medicine
  • Regenerative Medicine
  • Cell-cultured Meat
  • Healthcare
  • Biotechnology
  • Pharmaceutical
AI Sentiment